The Notch signaling regulates CD105 expression, osteogenic differentiation and immunomodulation of human umbilical cord mesenchymal stem cells

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Na, Tao ^a   Liu, Jing ^a   Zhang, Kehua ^a   Ding, Min ^b   Yuan, Bao Zhu ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BORTEZOMIB; CASPASE; CASPASE 3; CASPASE 7; ENDOGLIN; GAMMA INTERFERON; GAMMA SECRETASE INHIBITOR; HISTONE H2AX; INDOLEAMINE 2,3 DIOXYGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; P21 ACTIVATED KINASE; PROTEASOME; PROTEIN KINASE B; PROTEIN MCL 1; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; THY 1 ANTIGEN; BENZYLOXYCARBONYL-LEUCYL-LEUCYL-NORLEUCINAL; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; LEUKOCYTE ANTIGEN; OLIGOPEPTIDE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPRECIPITATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL; UMBILICAL CORD; WESTERN BLOTTING; CELL CULTURE; CELL PROLIFERATION; COCULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MESENCHYMAL STROMAL CELLS; OLIGOPEPTIDES; OSTEOGENESIS; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TH1 CELLS; UMBILICAL CORD;

EID: 84923306673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118168     Document Type: Article

References (53)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247. PMID: 5654088
2. In't Anker PS, Scherjon SA, Kleijburg-Van Der Keur C, De Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338-1345. PMID: 15579651
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49. PMID: 12077603
4. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311-324. PMID: 15319535
5. Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110. PMID: 12529557
6. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. PMID: 16923606
7. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L (2004) Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340:141-150. PMID: 15556302
8. Ode A, Kopf J, Kurtz A, Schmidt-Bleek K, Schrade P, et al. (2011) CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. Eur Cell Mater 22:26-42. PMID: 21732280
9. Wiesmann A, Buhring HJ, Mentrup C, Wiesmann HP (2006) Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head Face Med 2:8. PMID: 16573842
10. Romieu-Mourez R, Francois M, Boivin MN, Bouchentouf M, Spaner DE, et al. (2009) Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182:7963-7973. doi: 10.4049/jimmunol.0803864 PMID: 19494321
11. Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, Nova-Lamperti E, et al. (2013) Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4:65. doi: 10.1186/scrt216 PMID: 23734780
12. Soleymaninejadian E, Pramanik K, Samadian E (2012) Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 67:1-8. doi: 10.1111/j.1600-0897.2011. 01069.x PMID: 21951555
13. Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO (2009) Indoleamine 2, 3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 60:1342-1351. doi: 10.1002/art.24446 PMID: 19404944
14. Shi Y, Hu G, Su J, Li W, Chen Q, et al. (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 20:510-518. doi: 10.1038/cr.2010.44 PMID: 20368733
15. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, et al. (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185:5953-5961. doi: 10.4049/jimmunol.1001628 PMID: 20944000
16. Yuan BZ, Wang J (2014) The regulatory sciences for stem cell-based medicinal products. Front Med 8:190-200. doi: 10.1007/s11684-014-0323-5 PMID: 24733351
17. Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204. PMID: 17316462
18. Osathanon T, Manokawinchoke J, Nowwarote N, Aguilar P, Palaga T, et al. (2013) Notch signaling is involved in neurogenic commitment of human periodontal ligament-derived mesenchymal stem cells. Stem Cells Dev 22:1220-1231. doi: 10.1089/scd.2012.0430 PMID: 23379739
19. Suman S, Das TP, Damodaran C (2013) Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells. Br J Cancer 109:2587-2596. doi: 10.1038/bjc.2013. 642 PMID: 24129237
20. Koorella C, Nair JR, Murray ME, Carlson LM, Watkins SK, et al. (2014) Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2, 3-dioxygenase production by dendritic cells. J Biol Chem 289:7747-7762. doi: 10.1074/jbc. M113.519686 PMID: 24415757
21. Del Papa B, Sportoletti P, Cecchini D, Rosati E, Balucani C, et al. (2013) Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. Eur J Immunol 43:182-187. doi: 10.1002/eji. 201242643 PMID: 23161436
22. La Voie MJ, Selkoe DJ (2003) The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments. J Biol Chem 278:34427-34437. PMID: 12826675
23. Iso T, Kedes L, Hamamori Y (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194:237-255. PMID: 12548545
24. Kornilova AY, Das C, Wolfe MS (2003) Differential effects of inhibitors on the gamma-secretase complex. Mechanistic implications. J Biol Chem 278:16470-16473. PMID: 12644463
25. Biskup E, Kamstrup MR, Manfe V, Gniadecki R (2013) Proteasome inhibition as a novel mechanism of the proapoptotic activity of gamma-secretase inhibitor I in cutaneous T-cell lymphoma. Br J Dermatol 168:504-512. doi: 10.1111/bjd.12071 PMID: 23445313
26. Han J, Ma I, Hendzel MJ, Allalunis-Turner J (2009) The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. Breast Cancer Res 11:R57. doi: 10.1186/bcr2347 PMID: 19660128
27. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, et al. (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026. PMID: 16870554
28. Vissers MC, Jester SA, Fantone JC (1988) Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol Methods 110:203-207. PMID: 2837516
29. Zhang K, Na T, Wang L, Gao Q, Yin W, et al. (2014) Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells. Vaccine. doi: 10.1016/j.vaccine. 2014.12.013 PMID: 25556592
30. Charoenpanich A, Wall ME, Tucker CJ, Andrews DM, Lalush DS, et al. (2011) Microarray analysis of human adipose-derived stem cells in three-dimensional collagen culture: osteogenesis inhibits bone morphogenic protein and Wnt signaling pathways, and cyclic tensile strain causes upregulation of proinflammatory cytokine regulators and angiogenic factors. Tissue Eng Part A 17:2615-2627. doi: 10.1089/ten. tea.2011.0107 PMID: 21767168
31. Yuan BZ, Chapman JA, Reynolds SH (2008) Proteasome Inhibitor MG132 Induces Apoptosis and Inhibits Invasion of Human Malignant Pleural Mesothelioma Cells. Transl Oncol 1:129-140. PMID: 18795123
32. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, et al. (2009) Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15:452-459. doi: 10.1158/1078-0432. CCR-08-1631 PMID: 19147749
33. Soichot M, Hennart B, Al Saabi A, Leloire A, Froguel P, et al. (2011) Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene. PLoS One 6:e25470. doi: 10.1371/journal.pone.0025470 PMID: 21980470
34. Yuan BZ, Chapman J, Reynolds SH (2009) Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage. Oncogene 28:3775-3786. doi: 10.1038/onc.2009.240 PMID: 19684616
35. Kosmacheva SM, Volk MV, Yeustratenka TA, Severin IN, Potapnev MP (2008) In vitro growth of human umbilical blood mesenchymal stem cells and their differentiation into chondrocytes and osteoblasts. Bull Exp Biol Med 145:141-145. PMID: 19024023
36. Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7:678-689. PMID: 16921404
37. Xu S, Evans H, Buckle C, De Veirman K, Hu J, et al. (2012) Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia 26:2546-2549. doi: 10.1038/leu.2012.126 PMID: 22652628
38. Zhu F, Sweetwyne MT, Hankenson KD (2013) PKCdelta is required for Jagged-1 induction of human mesenchymal stem cell osteogenic differentiation. Stem Cells 31:1181-1192. doi: 10.1002/stem.1353 PMID: 23404789
39. Meng X, Matlawska-Wasowska K, Girodon F, Mazel T, Willman CL, et al. (2011) GSI-I (Z-LLNle-CHO) inhibits gamma-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia. Leukemia 25:1135-1146. doi: 10.1038/leu.2011.50 PMID: 21494254
40. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, et al. (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28:5-16. doi: 10.1002/stem.254 PMID: 19904829
41. McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, et al. (2012) Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A 109:E2939-2948. doi: 10.1073/pnas.1206400109 PMID: 23019585
42. Haapasalo A, Kovacs DM (2011) The many substrates of presenilin/gamma-secretase. J Alzheimers Dis 25:3-28. doi: 10.3233/JAD-2011-101065 PMID: 21335653
43. Yuan BZ, Chapman J, Ding M, Wang J, Jiang B, et al. (2013) TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages. BMC Cancer 13:140. doi: 10.1186/1471-2407-13-140 PMID: 23517112
44. Flood F, Murphy S, Cowburn RF, Lannfelt L, Walker B, et al. (2005) Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site. Biochem J 385:545-550. PMID: 15473868
45. Aslan H, Zilberman Y, Kandel L, Liebergall M, Oskouian RJ, et al. (2006) Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24:1728-1737. PMID: 16601078
46. Mark P, Kleinsorge M, Gaebel R, Lux CA, Toelk A, et al. (2013) Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium. Stem Cells Int 2013:698076. doi: 10.1155/2013/698076 PMID: 24194767
47. Rosu-Myles M, She YM, Fair J, Muradia G, Mehic J, et al. (2012) Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells. PLoS One 7:e38954. doi: 10. 1371/journal.pone.0038954 PMID: 22719999
48. Ugarte F, Ryser M, Thieme S, Fierro FA, Navratiel K, et al. (2009) Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37:867-875 e861. doi: 10.1016/j.exphem.2009.03.007 PMID: 19540436
49. Park ES, Lind AK, Dahm-Kahler P, Brannstrom M, Carletti MZ, et al. (2010) RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries. Mol Endocrinol 24:846-858. doi: 10.1210/me.2009-0392 PMID: 20197312
50. Lin GL, Hankenson KD (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112:3491-3501. doi: 10.1002/jcb.23287 PMID: 21793042
51. Costa-Pinto AR, Correlo VM, Sol PC, Bhattacharya M, Charbord P, et al. (2009) Osteogenic differentiation of human bone marrow mesenchymal stem cells seeded on melt based chitosan scaffolds for bone tissue engineering applications. Biomacromolecules 10:2067-2073. doi: 10.1021/bm9000102 PMID: 19621927
52. Lotfinegad P, Shamsasenjan K, Movassaghpour A, Majidi J, Baradaran B (2014) Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. Adv Pharm Bull 4:5-13. doi: 10.5681/apb.2014.002 PMID: 24409403
53. Ma S, Xie N, Li W, Yuan B, Shi Y, et al. (2014) Immunobiology of mesenchymal stem cells. Cell Death Differ 21:216-225. doi: 10.1038/cdd.2013.158 PMID: 24185619